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ABSTRACT
Objective To assess the correlation between intratumoral
vascularization using three-dimensional power Doppler
angiography (3D-PDA) and several histological tumor
characteristics in a series of patients with endometrial
carcinoma.
Methods Ninety-nine women (mean age, 61.7 (range,
31–84) years) diagnosed as having endometrial cancer
were assessed by transvaginal 3D-PDA before surgical
staging. Endometrial volume (EV) and 3D-PDA vascular
indices (vascularization index (VI), flow index (FI)
and vascularization flow index (VFI)) were calculated
using the Virtual Organ Computer-aided AnaLysis
(VOCAL
TM
) method. All patients were surgically staged.
Individual tumor features such as histological type,
tumor grade, myometrial infiltration depth, lymph-
vascular space involvement, cervical involvement, lymph
node metastases and tumor stage were considered for
analysis. Multivariate logistic regression (MLR) analysis
was used to determine which 3D-PDA parameters
were independently associated with each histological
characteristic.
Results MLR analysis showed that only EV and VI were
independently associated with myometrial infiltration
(EV: odds ratio (OR), 1.119 (95% CI, 1.025–1.221), P =
0.012; VI: OR, 1.127 (95% CI, 1.063–1.195), P = 0.001)
and tumor stage (EV: OR, 1.103 (95% CI, 1.012–1.202),
P = 0.025; VI: OR, 1.120 (95% CI, 1.057–1.187), P =
0.001), only VI was independently associated with tumor
grade (OR, 1.056 (95% CI, 1.023–1.091), P = 0.001)
and only EV was independently associated with lymph
node metastases (OR, 1.086 (95% CI, 1.017–1.161),
P = 0.001).
Conclusion 3D-PDA analysis of tumor vascularization
in endometrial cancer correlates with some prognostic
histological characteristics. Copyright  2010 ISUOG.
Published by John Wiley & Sons, Ltd.
INTRODUCTION
Angiogenesis plays a crucial role in tumor growth and
mestastasis1. Specifically, it has been shown to be an
important event in the development of endometrial
cancer2. Two-dimensional (2D) Doppler ultrasound
allows in-vivo assessment of tumor vascularization3,
which in turns reflects tumor angiogenesis4. This
technique has been applied for assessing angiogenesis
in endometrial cancer and its correlation with tumor
features, but with conflicting results5–11.
Three-dimensional (3D) ultrasonography and power
Doppler angiography (PDA) has been introduced as a
new sonographic diagnostic tool. This technology allows
acquisition of an endometrial volume and evaluation of
the vascularity of the entire endometrium using 3D power
Doppler mapping. Using Virtual Organ Computer-aided
AnaLysis (VOCAL
TM
) software, three vascularity indices
can be calculated automatically: the vascularization index
(VI), the flow index (FI) and the vascularization flow
index (VFI)12. This technique has been shown to have
high reproducibility for assessing endometrial volume
and 3D power Doppler indices in cases of endometrial
cancer13.
The aim of this study was to assess the correlation of
intratumoral vascularization using 3D-PDA with several
individual tumor characteristics in a series of patients with
endometrial carcinoma.
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METHODS
Patients
Institutional review board approval was obtained before
starting the study and all women gave verbal informed
consent. From January 2004 to December 2008, 118
consecutive women diagnosed as having endometrial
cancer were recruited for this prospective observational
study. Patients were collected at two centers: Clinica
Universitaria de Navarra, Pamplona, Spain (n = 102
(86%)) and Ruber International Hospital, Madrid, Spain
(n = 16 (14%)). All patients had histologically proven
endometrial cancer following office microcurettage or
hysteroscopic biopsy and were scheduled for surgical
staging.
We excluded 19 women from the study for the
following reasons: surgery not performed (n = 4), final
histological diagnosis other than epithelial endometrial
cancer (n = 6), incomplete pathological report (n = 4),
or 3D volume not adequate (n = 5), either because
the endometrium was not included completely within
the volume (n = 2) or there was an intrauterine fluid
collection that disturbed endometrial volume assessment
(n = 3).
Ultrasound examination
All sonographic examinations were performed within
1 week prior to surgery, with patients in the lithotomy
position and their bladder empty, using a Voluson 730
Expert (GE Healthcare, Milwaukee, WI, USA) machine
equipped with a multi-frequency endovaginal probe
(3–9 MHz). Three operators (J.L.A., L.M. and R.G.)
with 7, 7 and 3 years’ experience in 3D ultrasound,
respectively, performed all examinations according to
a predetermined strict scanning protocol13. A 2D
ultrasound exploration of the uterus and adnexa was
carried out initially. Endometrial thickness was measured
in the sagittal plane, including both layers, at the
level of maximal thickness. After B-mode evaluation,
the 2D power-Doppler gate was activated to assess
vascularization of the myometrium and endometrium.
Power Doppler settings were set to achieve maximum
sensitivity to detect low velocity flow without noise
(frequency, 5 MHz; power Doppler gain, 0.8; dynamic
range, 20–40 dB; edge, 1; persistence, 2; color map, 5;
gate, 2; filter, L1; pulse repetition frequency, 0.6 kHz).
The 3D volume was then activated to obtain a 3D
box from the uterus. Using a sweeping angle of 90◦,
the acquisition box of the 3D volume was placed
over the power Doppler window. Asking the patient
to remain as still as possible, volume acquisition was
performed during a 15–20-s time interval. Volume
acquisition was repeated if there were flash-type artifacts
due to respiratory or intestinal movements. In four
(4%) cases no color signal was detected within the
endometrium, but these cases were not excluded from
analysis.
Stored volume analysis
Two examiners (J.L.A. and L.M.) performed all volume
analyses. Examiners knew patients had cancer but they
were blinded to definitive histological results. Using the
VOCAL program (4DView software, GE Healthcare),
the endometrial area was outlined manually in the
coronal plane. Using a rotational technique with a 9◦
step, 20 endometrial slices were obtained outlining the
endometrium at the myometrial–endometrial junction
from the fundus to the internal cervical os. In those
cases in which cervical involvement was suspected on
ultrasound, we included this also in the 3D-volume
assessment (Figure 1). The 3D power Doppler indices
(VI, FI and VFI) were calculated automatically by the
VOCAL software (Figure 2). VI, expressed as percentage,
measures the number of color voxels in the studied
volume, representing the blood vessels within the tissue.
FI, expressed as a number ranging from 0 to 100, is the
average color value of all color voxels, representing the
average color intensity. VFI, also expressed as a number
ranging from 0 to 100, represents the mathematical
relationship between VI and FI.
Surgical staging
All patients underwent surgical staging. In most cases
this included total abdominal hysterectomy with bilat-
eral salpingo-oophorectomy, pelvic and para-aortic lymph
node dissection or sampling, pelvic and abdominal cyto-
logical washings and infracolic omentectomy. Para-aortic
sampling and infracolic omentectomy were not performed
in well-differentiated endometrioid adenocarcinomas with
≤ 50% myometrial infiltration at intraoperative frozen
section assessment.
In all cases, pathological data such as histological
type, tumor grade, myometrial infiltration depth, lymph-
vascular space involvement (LVSI), cervical involvement
and lymph node metastases were obtained. Tumor
histological grade was determined according to the three-
grade system, in which Grade 1 (G1) had gland formation
in > 95% of the tumor area, Grade 2 (G2) had a solid
growth pattern in 5–50% of the tumor and Grade 3 (G3)
had a solid pattern in > 50% of the tumor. Tumors were
staged according to FIGO criteria14.
For analytical purposes the following histological
characteristics were dichotomized: histological type:
endometrioid vs. other (including adenoachantoma,
adenosquamous, clear-cell, serous-papillary); histological
grade: G1–G2 vs. G3; myometrial infiltration: none or
< 50% vs. ≥ 50%; tumor stage: Ia–Ib vs. ≥ Ic.
Statistical analysis
Kolmogorov–Smirnov’s test was used to evaluate nor-
mal distribution of continuous data. All results are
presented as mean and SD values or as median and
interquartile range according to the distribution of
data. Categorical results are presented as numbers of
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Figure 1 Three-dimensional endometrial volume estimation in a case of endometrial cancer. The tumor arises from the isthmus and extends
to the cervix. Vascular Doppler signals are seen mainly at the level of the isthmus and the cervical channel is seen to be enlarged.
Figure 2 Three-dimensional power Doppler indices calculated from
the volume obtained in Figure 1: mean gray value (MG),
vascularization index (VI), flow index (FI) and vascularization flow
index (VFI).
cases and percentages. For univariate analysis, contin-
uous variables were compared using one-way analysis
of variance or the Mann–Whitney U-test, depending
on the distribution of raw data. Categorical variables
were compared using the chi-square test. Pearson’s cor-
relation coefficient was used to assess the correlation
between endometrial thickness and endometrial vol-
ume. Those variables found to be statistically significant
during univariate analysis then underwent multivari-
ate step forward logistic regression (MLR) analysis to
determine which were associated independently with
each histological characteristic. Receiver–operating char-
acteristics (ROC) curves were then plotted for those
variables found to be independently related to each
tumor feature in order to determine the best cut-
off. Sensitivity, specificity, positive likelihood ratios
(LR+) and negative likelihood ratios (LR−) were cal-
culated.
A significance level of P < 0.05 was used in all tests. All
statistical procedures were carried out using SPSS version
15 for Windows (SPSS Inc, Chicago, IL, USA).
RESULTS
Ninety-nine women were included in the final analysis.
Their mean age was 61.7 (range, 31–84) years. Eighty-
two (82.8%) were postmenopausal and seventeen
(17.2%) were premenopausal.
Tumor histological characteristics are shown in
Table 1. Lymph node sampling was not performed
in 29 patients with well-differentiated endometrioid
adenocarcinomas and < 50% myometrial infiltration on
frozen section analysis, due to the very low risk of
node involvement. These were considered as negative
for analysis.
Myometrial infiltration was related to histological grade
(deep myometrial infiltration was found in 81% of G3
tumors vs. 27% of G1–G2 tumors, P < 0.001). Lymph
node metastases was related to myometrial infiltration
(lymph node metastases were found in 31.5% of deeply
infiltrating tumors vs. 6.5% of superficially infiltrating
tumors, P < 0.001).
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Table 1 Histological characteristics of endometrial cancer (n = 99)
Characteristic n %
Histological type
Endometrioid 83 83.9
Adenosquamous 11 11.1
Serous-papillary 4 4.0
Clear-cell 1 1.0
Histological grade
Well differentiated (G1) 45 45.5
Moderately differentiated (G2) 33 33.3
Poorly differentiated (G3) 21 21.2
Myometrial infiltration
None* 13 13.1
<50% 48 48.5
≥ 50% 38 38.4
Cervical involvement
No 84 84.8
Yes 15 15.2
LVSI
No 87 87.8
Yes 12 12.2
Lymph node metastases*
No 83 83.8
Yes 16 16.2
Tumor stage
Ia 13 13.1
Ib 42 42.4
Ic 13 13.1
II 11 11.1
III 15 15.1
IV 5 5.1
*Definitive gold standard not available in 29 patients. LVSI,
lymph-vascular space involvement.
The mean endometrial thickness was 14.1 (SD, 7.6;
range, 1.0–39.8) mm. There were no statistically signifi-
cant differences regarding endometrial thickness accord-
ing to tumor type, tumor grade, cervical involvement,
lymph node metastases or LVSI. However, tumors with
deep myometrial infiltration and advanced stage had a
significantly thicker endometrium (Table 2). Endometrial
thickness was significantly correlated with endometrial
volume (r = 0.719, P < 0.001), so only endometrial vol-
ume, and not endometrial thickness, was entered in
the MRL analysis. There was one case of endome-
trial cancer with an ET of 1.0 mm. This was a 56-
year-old postmenopausal woman who was not taking
any kind of treatment and who presented with uter-
ine bleeding. The endometrium was quite thin on B-
mode ultrasound but on power Doppler examination
we noticed a significant amount of blood flow in a
focal area at the level of the myometrial–endometrial
interface as well as in the endometrium. For this
reason we performed endometrial biopsy and cancer
was detected. After hysterectomy, pathological anal-
ysis revealed a well-differentiated endometrioid carci-
noma (1.6 × 0.6 × 0.3 cm) infiltrating the myometrium
superficially.
There was no statistical difference for endometrial
volume according to tumor histological type (Table 2).
However, endometrial volume was significantly higher in
poorly differentiated tumors and deeply invasive tumors,
as well as in cases of cervical involvement, lymph node
metastases, positive LVSI and tumor stage ≥ Ic (Table 2).
Table 2 Endometrial volume (EV) and thickness (ET) according to different dichotomized histological characteristics of endometrial cancers
(n = 99)
EV ET
Characteristic EV (mL) P ET (mm) P
Histological type 0.191* 0.270*
Endometrioid 4.682 ± 6.6 13.8 ± 7.5
Non-endometrioid 7.901 ± 12.4 16.1 ± 8.0
Histological grade 0.003† 0.181†
Moderately–well differentiated (G1–G2) 4.576 (6.1) 12.6 (8.2)
Poorly differentiated (G3) 8.381 (10.5) 13.0 (10.0)
Myometrial infiltration 0.001† 0.001†
<50% 4.297 (4.5) 11.0 (6.0)
≥ 50% 8.862 (10.1) 17.3 (10.9)
Cervical involvement 0.035* 0.085*
No 4.632 ± 5.9 13.6 ± 7.7
Yes 9.020 ± 9.3 17.2 ± 7.4
LVSI 0.026† 0.223†
No 4.302 (5.7) 12.0 (6.5)
Yes 8.542 (9.9) 12.5 (20.5)
Lymph node metastases‡ 0.019* 0.106*
No 4.622 ± 6.2 13.6 ± 7.2
Yes 8.252 ± 13.1 16.9 ± 8.9
Tumor stage 0.001† 0.001†
Ia–Ib 3.338 (4.1) 10.0 (6.0)
≥ Ic 8.541 (9.4) 17.0 (9.5)
Data are expressed as mean ± SD or median (interquartile range). *ANOVA one-way test. †Mann–Whitney U-test. ‡Definitive gold
standard not available in 29 patients. LVSI, lymph-vascular space involvement.
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Table 3 Three-dimensional power Doppler angiography indices according to different dichotomized histological characteristics of
endometrial cancers (n = 99)
VI FI VFI
VI (%) P* FI P* VFI P*
Histological type 0.190 0.171 0.658
Endometrioid 8.271 (16.0) 30.200 (11.4) 2.335 (4.8)
Non-endometrioid 16.248 (31.4) 32.164 (12.4) 4.799 (11.5)
Histological grade 0.001 0.028 0.001
Moderately–well differentiated (G1–G2) 7.311 (13.8) 29.211 (11.4) 2.042 (4.3)
Poorly differentiated (G3) 22.000 (28.6) 33.167 (5.2) 6.101 (8.4)
Myometrial infiltration 0.001 0.001 0.001
<50% 3.110 (10.9) 26.510 (9.7) 0.813 (3.0)
≥ 50% 23.915 (26.1) 34.731 (6.4) 7.372 (10.3)
Cervical involvement 0.003 0.008 0.002
No 7.585 (16.6) 29.910 (11.9) 2.193 (4.9)
Yes 17.612 (35.3) 33.617 (10.1) 6.101 (11.1)
LVSI 0.046 0.008 0.041
No 7.307 (16.3) 29.100 (11.9) 1.574 (4.4)
Yes 16.306 (32.1) 36.422 (5.1) 6.221 (11.4)
Lymph node metastases† 0.023 0.071 0.039
No 7.315 (16.1) 30.157 (12.8) 2.077 (5.2)
Yes 14.550 (14.5) 33.614 (6.9) 4.369 (4.0)
Tumor stage 0.001 0.001 0.001
Ia–Ib 3.052 (9.5) 26.427 (10.2) 0.765 (2.3)
≥ Ic 18.641 (25.3) 33.614 (6.7) 5.715 (9.7)
Data are expressed as median (interquartile range). *Mann–Whitney U-test. †Definitive gold standard not available in 29 patients. FI, flow
index; LVSI, lymph-vascular space involvement; VFI, vascularization flow index; VI, vascularization index.
Regarding 3D-PDA analysis, as expected, in those
four cases without blood flow detected, the VI, FI
and VFI values were 0. However, these cases were
included in the final analysis. Their histological types
included two endometrioid adenocarcinomas, one serous-
papillary adenocarcinoma and one adenosquamous
carcinoma. As with endometrial volume, there were no
statistical differences for VI, FI and VFI according to
tumor histological type (Table 3), while all three were
significantly higher in poorly differentiated tumors and
deeply invasive tumors, as well as in cases of cervical
involvement, lymph node metastases, positive LVSI and
tumor stage ≥ Ic, except in the case of FI according to
lymph node metastases (Table 3).
MLR analysis revealed that only endometrial volume
and VI were independently associated with myometrial
infiltration and tumor stage (Table 4), only VI was
independently associated with tumor grade and only
endometrial volume was associated with lymph node
metastases. Neither endometrial volume nor 3D-PDA
indices was independently associated with cervical
involvement or LVSI.
ROC curves showed that the best cut-off for
predicting deep myometrial infiltration was 2.328 cm3
for endometrial volume (sensitivity, 92%; specificity,
38%; LR+, 1.5 (95% CI, 1.2–1.8); LR−, 0.2 (95%
CI, 0.1–0.7)) and 6.950% for VI (sensitivity, 92%;
specificity, 62%; LR+, 2.5 (95% CI, 1.7–3.6); LR−,
0.1 (95% CI, 0.04–0.4)). The best cut-off for predicting
tumor stage ≥ Ic was 3.960 cm3 for endometrial volume
(sensitivity, 89%; specificity, 60%; LR+, 2.2 (95% CI,
Table 4 Multivariate logistic regression analysis for histological
characteristics of endometrial cancers (n = 99)
Coefficient Odds ratio (95% CI) P
Myometrial infiltration
Endometrial volume 0.112 1.119 (1.025–1.221) 0.012
VI 0.119 1.127 (1.063–1.195) 0.001
Tumor stage
Endometrial volume 0.098 1.103 (1.012–1.202) 0.025
VI 0.114 1.120 (1.057–1.187) 0.001
Lymph node metastases
Endometrial volume 0.083 1.086 (1.017–1.161) 0.001
Tumor grade
VI 0.055 1.056 (1.023–1.091) 0.001
VI, vascularization index.
1.6–3.1); LR−, 0.2 (95% CI, 0.1–0.4)) and 7.343% for
VI (sensitivity, 86%; specificity, 69%; LR+, 2.8 (95%
CI, 1.8–4.2); LR−, 0.2 (95% CI, 0.1–0.4)). The best
cut-off for endometrial volume for predicting lymph node
metastases was 4.632 cm3 (sensitivity, 81%; specificity,
51%; LR+, 1.6 (95% CI, 1.2–2.3); LR−, 0.4 (95% CI,
0.1–0.9)). The best cut-off for VI for predicting poor
differentiated histological grade was 9.821% (sensitivity,
81%; specificity, 60%; LR+, 2.0 (95% CI, 1.4–2.9);
LR−, 0.3 (95% CI 0.1–0.8)).
DISCUSSION
Our results showed that endometrial volume and
3D vascular indices correlated with most individual
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tumor histological characteristics. Interestingly, both
endometrial volume and VI were related independently
to myometrial infiltration depth and tumor stage,
whereas only VI was related to tumor grade and
only endometrial volume was related with lymph node
metastases. These results make sense if we consider current
knowledge derived from histological data. The risk of deep
myometrial infiltration is known to increase with tumor
size15 and angiogenesis is higher in poorly differentiated
tumors16,17. Myometrial infiltration and tumor grade are
the two most important histological factors associated
with lymph node metastases18. Furthermore, angiogenesis
itself has been shown to be an independent prognostic
indicator in endometrial carcinoma19–21.
It has been shown that the use of color Doppler ultra-
sound allows the preoperative in-vivo assessment of tumor
angiogenesis4. It seems logical, therefore, to suppose that
tumor blood flow could be correlated with individual
tumor histological features. Yet, several papers assess-
ing the correlation between pulsed Doppler velocimetric
indices and tumor characteristics in endometrial cancer
have produced conflicting results. Some authors did not
observe any relation between intratumoral Doppler and
tumoral stage, histological grade, myometrial infiltration
and metastases in the lymphatic nodes5,6,8, while oth-
ers found that intratumoral pulsed Doppler correlates
with tumor grade and can predict tumoral dissemination
both at a regional level (myometrium and cervix) and at
a distance (lymph nodes)7,9–11. These conflicting results
could be explained by the low reproducibility of pulsed
Doppler measurements and the overlapping observed for
velocimetric indices11,22.
3D power Doppler seems capable of overcoming at
least one of these limitations: reproducibility of the
technique. Several papers have shown high interobserver
reproducibility for endometrial volume calculations and
3D vascular index estimation12,23. Specifically, we have
demonstrated this in cases of tumoral endometria13. To
date, however, very few studies have evaluated the role
of 3D power Doppler in the assessment of endometrial
pathology. Odeh et al.24 and Merce´ et al.25 showed that
endometrial cancer exhibits a higher vascularization as
assessed by 3D-PDA than does endometrial hyperplasia,
and this was recently confirmed by our group26, but, to
our knowledge, no study has analyzed the correlation of
tumor vascularity as assessed by 3D-PDA and individual
endometrial tumor characteristics.
De Smet et al.27 analyzed the correlation between
endometrial volume and myometrial infiltration in a
series of 97 women with endometrial cancer. Using MLR
analysis they found that the predicted probability of deep
myometrial infiltration increased when the endometrial
thickness increased, while this probability decreased when
endometrial volume increased. The authors themselves
remarked that this was an unexpected finding but could be
explained by non-linear effects. However, they calculated
endometrial volume according to the formula for a prolate
ellipsoid, while we used a 3D rotational method. For this
reason our results might not be comparable.
Although our findings are interesting, the application
of these results in clinical practice may be limited as
we observed some overlapping of 3D-PDA values, which
could make it difficult to establish a clinically useful
cut-off. In fact, the overall diagnostic performance for
predicting myometrial infiltration, tumor grade, lymph
node metastases and tumor stage was only moderate with
the best cut-offs we determined.
In conclusion, although our series was relatively
small, our data indicate that 3D-PDA analysis of
tumor vascularization in endometrial cancer correlates
with some prognostic histological characteristics. Further
studies in larger series are needed to confirm or refute
these preliminary data.
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